Solv
PrivateLast Round
Series C
Sep 2, 2021
Est. Valuation
$146.67M
Total Funding Raised
$95.05M
Company Overview
Solv operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a Series C round in September 2021.
Solv is a healthcare technology company that provides an AI-first platform for on-demand care, enabling medical providers to automate patient access, scheduling, insurance verification, and revenue workflows.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Telemedicine, NLP & Conversational AI, Revenue Cycle, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Payment Processing Fee
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solv Comparables
Compare Solv with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Experity | 82% | |
| Medimap | 77% | |
| Luma Health | 77% |
For institutional investors. Book with your work email.
Solv Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 2, 2021 | ||||
| Series B Extension | Nov 12, 2020 | ||||
| Series B | May 8, 2018 | ||||
| Series A | Apr 19, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Solv Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benchmark Capital | Series B, Series B Extension, Series A, Series C |
| NFX | Series A |
| Greylock Partners | Series B Extension, Series C, Series B |
| Aspect Ventures | Series B, Series A |
| Corner Ventures | Series C |
| Acrew Capital | Series B Extension, Series C |
| Light Street Investements | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Launched an AI-first operating system for healthcare providers.
- Jan 12, 2026
Added ConvenientMD LLC as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withSep 1, 2026
On Sep 1st '26, Solv Health, Inc. integrates with Amazon.com Inc. to show patients real-time prescription delivery options, including same-day delivery, during the medical appointment booking process.
For institutional investors. Book with your work email.
Solv Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Solv's valuation, stock price, and market status.
Is Solv a public or private company?
Solv is a private company.
What is the current stock price of Solv?
Solv is a private company, so its shares have no public market price. Caplight tracks Solv's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Solv worth (valuation)?
Solv's valuation is estimated at $146.7M based on funding round data.
Can I buy Solv stock?
Solv shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Solv's last funding round?
Solv's most recent funding round was Series C on September 2, 2021.
Who are the main investors in Solv?
Key investors in Solv include Greylock Partners, Corner Ventures, Acrew Capital, Corner Ventures.
Will Solv IPO soon?
No public IPO plans have been announced for Solv.
How can I track Solv secondary market activity?
Caplight tracks bids, offers, and trades in Solv's shares on secondary markets.